Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ovarian Neoplasms

  Free Subscription


12.02.2024

1 BMC Cancer
1 Br J Cancer
1 Cancer
3 Gynecol Oncol
2 Histopathology
4 Int J Gynecol Pathol
1 J Clin Oncol
1 Oncology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. JAMALZADEH S, Dai J, Lavikka K, Li Y, et al
    Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.
    BMC Cancer. 2024;24:173.
    PubMed         Abstract available


    Br J Cancer

  2. POSTEL-VINAY S, Coves J, Texier M, Aldea M, et al
    Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02514.
    PubMed         Abstract available


    Cancer

  3. PARK S, Kim YJ, Min YJ, Mortimer PGS, et al
    Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
    Cancer. 2023 Oct 16. doi: 10.1002/cncr.35059.
    PubMed         Abstract available


    Gynecol Oncol

  4. POTHURI B, Han S, Chase DM, Heitz F, et al
    Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
    Gynecol Oncol. 2024;184:168-177.
    PubMed         Abstract available

  5. TELLES R, Zimmerman MB, Thaker PH, Slavich GM, et al
    Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients.
    Gynecol Oncol. 2024;184:139-145.
    PubMed         Abstract available

  6. HARI A, Chang J, Villanueva C, Ziogas A, et al
    Short-term survival analysis of a risk-adjusted model for ovarian cancer care.
    Gynecol Oncol. 2024;184:123-131.
    PubMed         Abstract available


    Histopathology

  7. KOMMOSS FKF
    Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
    Histopathology. 2024;84:712-714.
    PubMed         Abstract available

  8. KOMMOSS FKF, Chong AS, Apellaniz-Ruiz M, Turashvili G, et al
    Teratoma-associated and so-called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features.
    Histopathology. 2024;84:683-696.
    PubMed         Abstract available


    Int J Gynecol Pathol

  9. XU J, McGregor SM, Park KJ, Weisman PS, et al
    Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
    Int J Gynecol Pathol. 2024;43:145-148.
    PubMed        

  10. BHARDWAJ S, Banet N, Gaston EC
    Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
    Int J Gynecol Pathol. 2024;43:140-144.
    PubMed         Abstract available

  11. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
    HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Int J Gynecol Pathol. 2024;43:134-139.
    PubMed         Abstract available

  12. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
    Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Int J Gynecol Pathol. 2024;43:123-133.
    PubMed         Abstract available


    J Clin Oncol

  13. LORUSSO D, Raspagliesi F, Ronzulli D, Valabrega G, et al
    Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
    J Clin Oncol. 2024 Feb 5:JCO2301225. doi: 10.1200/JCO.23.01225.
    PubMed         Abstract available


    Oncology

  14. MIYAGAWA Y, Kitazawa M, Tokumaru S, Nakamura S, et al
    Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
    Oncology. 2024;102:114-121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.